Who should own network segmentation when patient safety, compliance, and infrastructure teams all have a stake?

Ownership should be shared, but accountability must be explicit. Security teams should define policy intent and risk tolerance, network teams should implement and maintain enforcement, and clinical or biomedical owners should validate that workflows still function. Compliance should verify alignment with HIPAA and internal controls. Without clear accountability, segmentation projects fail through exception sprawl, weak governance, and unresolved operational disputes.

Why This Matters for Security Teams

network segmentation in healthcare is rarely just a technical design choice. It affects patient safety, downtime tolerance, audit evidence, and how quickly teams can isolate a device or clinical application during an incident. When ownership is vague, segmentation is often treated as a networking project, while the real risk is that business owners, security leaders, and biomedical engineers all assume someone else has already approved the operational tradeoff. Current guidance suggests that segmentation should be governed as a control objective, not a routing exercise, with explicit accountability for policy, implementation, and clinical validation. The NIST Cybersecurity Framework 2.0 is useful here because it frames governance, protection, and resilience as shared outcomes rather than isolated team tasks.

The practical challenge is that segmentation decisions often create hidden dependencies. A rule that looks sound on paper can break imaging workflows, medical device management, or access paths used during emergencies. That means ownership has to cover not only who configures the firewall, but who approves exceptions, who tests failover, and who accepts residual risk. In practice, many security teams encounter segmentation failure only after an outage or emergency access issue has already exposed the gaps in decision-making, rather than through intentional governance.

How It Works in Practice

A workable ownership model separates accountability from execution. Security should define the segmentation policy intent: which zones exist, what traffic is allowed, what risk is unacceptable, and how exceptions are reviewed. Network or infrastructure teams should implement the controls in firewalls, VLANs, ACLs, SDN policy, or microsegmentation tools. Clinical, biomedical, and application owners should verify that care delivery, monitoring, maintenance, and break-glass access still operate as intended. Compliance then checks that the operating model aligns with policy, documentation, and regulatory obligations.

That structure maps well to NIST SP 800-207 Zero Trust Architecture, where access decisions are policy-driven and continuously evaluated rather than assumed from network location. It also fits the control logic in NIST SP 800-53 Rev 5 Security and Privacy Controls, especially where boundaries, authorization, monitoring, and contingency handling need to be defensible.

A practical operating model usually includes:

• a RACI or equivalent decision matrix for policy approval, implementation, testing, and exception handling;
• documented zone definitions for clinical, administrative, vendor, and biomedical systems;
• change control that requires business validation before production rollout;
• an exception register with expiry dates and review owners;
• incident playbooks that describe how to isolate a segment without delaying urgent care.

This guidance breaks down in environments with legacy medical devices, flat networks, or unmanaged vendor support paths because the team implementing segmentation may not control all endpoints or all maintenance dependencies.

Common Variations and Edge Cases

Tighter segmentation often increases operational overhead, requiring organisations to balance isolation benefits against workflow disruption and support complexity. That tradeoff is especially sharp in hospitals, where clinical continuity can outweigh the elegance of a clean network design. In mature environments, the best practice is evolving toward policy-based segmentation with frequent review, but there is no universal standard for how much exception handling is acceptable.

Some edge cases need special handling. Vendor-managed devices may require temporary access paths that cannot be eliminated immediately. Shared platforms such as imaging, lab, or building systems may support multiple departments and therefore need mixed trust zones. Emergency access can also justify controlled bypass routes, but those routes should be tightly logged and time-bound. Where segmentation supports regulated data handling, the governance model should be aligned with broader management systems such as ISO/IEC 27001 and ISO/IEC 27002, but those standards do not remove the need for local operational ownership.

The key question is not only who approves the diagram, but who can be held responsible when the diagram and the clinical reality diverge. That distinction matters most when a security control is correct in principle but still unusable in a live care environment.

Related resources from NHI Mgmt Group

• Who should own controls for preventing AI infrastructure hijacking across cloud and identity teams?
• How should security teams govern non-human identities for compliance?
• How should security teams govern non-human identities for SOC 2 compliance?
• Who should own AI production risk when platform, infrastructure, and security teams all have a stake?